Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
The San Antonio breast cancer update presented final results with no further updates at the meeting. The potential for accelerated approval in breast cancer registration study was discussed, aiming for comparable results to Bracelet study. Efficient patient enrollment is expected for the first-line PDAC trial.